[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dyadic International (DYAI)

Dyadic International (DYAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,362
  • Shares Outstanding, K 36,439
  • Annual Sales, $ 3,090 K
  • Annual Income, $ -7,360 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.15
  • Price/Sales 14.27
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 686.28% (-93.05%)
  • Historical Volatility 127.52%
  • IV Percentile 79%
  • IV Rank 52.66%
  • IV High 1,199.56% on 02/12/26
  • IV Low 115.21% on 05/13/26
  • Expected Move (DTE 24) 0.0255 (2.26%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 23
  • Volume Avg (30-Day) 303
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3,413
  • Open Int (30-Day) 2,162
  • Expected Range 1.1045 to 1.1555

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.03
  • Number of Estimates 1
  • High Estimate $-0.03
  • Low Estimate $-0.03
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +32.94%
on 06/29/26
1.6000 -29.38%
on 07/22/26
+0.3290 (+41.07%)
since 06/26/26
3-Month
0.6568 +72.05%
on 06/11/26
1.6000 -29.38%
on 07/22/26
+0.3100 (+37.80%)
since 04/27/26
52-Week
0.6546 +72.62%
on 03/26/26
1.6000 -29.38%
on 07/22/26
+0.0300 (+2.73%)
since 07/25/25

Most Recent Stories

More News
Dyadic Announces Continued Listing on the Nasdaq Capital Market

JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant...

DYAI : 1.1300 (-5.04%)
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

JUPITER, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic" or the "Company"), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant...

DYAI : 1.1300 (-5.04%)
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

JUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the...

DYAI : 1.1300 (-5.04%)
Dyadic Expands IP Protection and Business Development Activities in Japan

JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the...

DYAI : 1.1300 (-5.04%)
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets

SmallCaps Daily Sits Down with Joe Hazelton to Discuss Dyadic's Product Strategy, Strategic Partnerships, and Long-Term Growth VisionNew York, New York--(Newsfile Corp. - June 22, 2026) - Dyadic Applied...

DYAI : 1.1300 (-5.04%)
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

JUPITER, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) , d/b/a Dyadic Applied BioSolutions (“Dyadic” or the “Company”), a biotechnology company focused...

DYAI : 1.1300 (-5.04%)
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

JUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic,” “we,” “us,” “our,” or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a biotechnology...

DYAI : 1.1300 (-5.04%)
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference

JUPITER, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic,” “we,” “us,” “our,” or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global...

DYAI : 1.1300 (-5.04%)
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress

Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industry Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals...

DYAI : 1.1300 (-5.04%)
Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026

JUPITER, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company...

DYAI : 1.1300 (-5.04%)

Business Summary

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms...

See More

Key Turning Points

3rd Resistance Point 1.2683
2nd Resistance Point 1.2367
1st Resistance Point 1.1833
Last Price 1.1300
1st Support Level 1.0983
2nd Support Level 1.0667
3rd Support Level 1.0133

See More

52-Week High 1.6000
Fibonacci 61.8% 1.2389
Last Price 1.1300
Fibonacci 50% 1.1273
Fibonacci 38.2% 1.0157
52-Week Low 0.6546

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.